vs
Cytek Biosciences, Inc.(CTKB)与UNITED STATES LIME & MINERALS INC(USLM)财务数据对比。点击上方公司名可切换其他公司
UNITED STATES LIME & MINERALS INC的季度营收约是Cytek Biosciences, Inc.的1.4倍($87.9M vs $62.1M),UNITED STATES LIME & MINERALS INC净利率更高(34.7% vs -70.9%,领先105.7%),UNITED STATES LIME & MINERALS INC同比增速更快(9.8% vs 8.1%),UNITED STATES LIME & MINERALS INC自由现金流更多($25.7M vs $-1.8M),过去两年Cytek Biosciences, Inc.的营收复合增速更高(17.7% vs 10.8%)
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化,产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域,客户遍及全球多个主要地区。
美国石灰矿产公司是总部位于美国的自然资源企业,主营高钙石灰、白云石石灰、石灰石及相关矿产制品,客户覆盖基建、钢铁制造、农业土壤改良、环保排放治理、工业加工等领域,业务主要辐射北美市场。
CTKB vs USLM — 直观对比
营收规模更大
USLM
是对方的1.4倍
$62.1M
营收增速更快
USLM
高出1.7%
8.1%
净利率更高
USLM
高出105.7%
-70.9%
自由现金流更多
USLM
多$27.4M
$-1.8M
两年增速更快
CTKB
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $62.1M | $87.9M |
| 净利润 | $-44.1M | $30.5M |
| 毛利率 | 52.9% | 48.0% |
| 营业利润率 | -9.0% | 41.0% |
| 净利率 | -70.9% | 34.7% |
| 营收同比 | 8.1% | 9.8% |
| 净利润同比 | -557.1% | 13.2% |
| 每股收益(稀释后) | — | $1.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CTKB
USLM
| Q4 25 | $62.1M | $87.9M | ||
| Q3 25 | $52.3M | $102.0M | ||
| Q2 25 | $45.6M | $91.5M | ||
| Q1 25 | $41.5M | $91.3M | ||
| Q4 24 | $57.5M | $80.1M | ||
| Q3 24 | $51.5M | $89.4M | ||
| Q2 24 | $46.6M | $76.5M | ||
| Q1 24 | $44.9M | $71.7M |
净利润
CTKB
USLM
| Q4 25 | $-44.1M | $30.5M | ||
| Q3 25 | $-5.5M | $38.8M | ||
| Q2 25 | $-5.6M | $30.8M | ||
| Q1 25 | $-11.4M | $34.1M | ||
| Q4 24 | $9.6M | $27.0M | ||
| Q3 24 | $941.0K | $33.4M | ||
| Q2 24 | $-10.4M | $26.1M | ||
| Q1 24 | $-6.2M | $22.4M |
毛利率
CTKB
USLM
| Q4 25 | 52.9% | 48.0% | ||
| Q3 25 | 52.7% | 51.2% | ||
| Q2 25 | 52.3% | 45.8% | ||
| Q1 25 | 48.6% | 50.6% | ||
| Q4 24 | 58.5% | 44.3% | ||
| Q3 24 | 56.3% | 48.2% | ||
| Q2 24 | 54.6% | 45.5% | ||
| Q1 24 | 51.3% | 42.7% |
营业利润率
CTKB
USLM
| Q4 25 | -9.0% | 41.0% | ||
| Q3 25 | -17.6% | 45.3% | ||
| Q2 25 | -23.3% | 39.0% | ||
| Q1 25 | -36.1% | 43.7% | ||
| Q4 24 | 5.2% | 38.8% | ||
| Q3 24 | -8.2% | 42.6% | ||
| Q2 24 | -18.3% | 39.1% | ||
| Q1 24 | -23.9% | 35.9% |
净利率
CTKB
USLM
| Q4 25 | -70.9% | 34.7% | ||
| Q3 25 | -10.5% | 38.0% | ||
| Q2 25 | -12.2% | 33.7% | ||
| Q1 25 | -27.5% | 37.4% | ||
| Q4 24 | 16.8% | 33.7% | ||
| Q3 24 | 1.8% | 37.3% | ||
| Q2 24 | -22.4% | 34.0% | ||
| Q1 24 | -13.8% | 31.3% |
每股收益(稀释后)
CTKB
USLM
| Q4 25 | — | $1.06 | ||
| Q3 25 | — | $1.35 | ||
| Q2 25 | — | $1.07 | ||
| Q1 25 | — | $1.19 | ||
| Q4 24 | — | $-2.20 | ||
| Q3 24 | — | $1.16 | ||
| Q2 24 | — | $0.91 | ||
| Q1 24 | — | $3.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | $371.1M |
| 总债务越低越好 | — | $0 |
| 股东权益账面价值 | $341.7M | $630.8M |
| 总资产 | $461.5M | $681.0M |
| 负债/权益比越低杠杆越低 | — | 0.00× |
8季度趋势,按日历期对齐
现金及短期投资
CTKB
USLM
| Q4 25 | $90.9M | $371.1M | ||
| Q3 25 | $93.3M | $349.5M | ||
| Q2 25 | $75.5M | $319.9M | ||
| Q1 25 | $95.3M | $300.6M | ||
| Q4 24 | $98.7M | $278.0M | ||
| Q3 24 | $162.3M | $255.0M | ||
| Q2 24 | $177.9M | $222.5M | ||
| Q1 24 | $168.8M | $207.0M |
总债务
CTKB
USLM
| Q4 25 | — | $0 | ||
| Q3 25 | — | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | — | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益
CTKB
USLM
| Q4 25 | $341.7M | $630.8M | ||
| Q3 25 | $378.6M | $602.3M | ||
| Q2 25 | $377.6M | $563.3M | ||
| Q1 25 | $379.6M | $532.2M | ||
| Q4 24 | $395.7M | $497.7M | ||
| Q3 24 | $385.5M | $474.2M | ||
| Q2 24 | $389.1M | $441.1M | ||
| Q1 24 | $392.6M | $415.3M |
总资产
CTKB
USLM
| Q4 25 | $461.5M | $681.0M | ||
| Q3 25 | $494.9M | $652.8M | ||
| Q2 25 | $493.3M | $607.4M | ||
| Q1 25 | $482.6M | $585.3M | ||
| Q4 24 | $499.5M | $543.2M | ||
| Q3 24 | $491.2M | $521.8M | ||
| Q2 24 | $483.7M | $484.2M | ||
| Q1 24 | $492.1M | $464.0M |
负债/权益比
CTKB
USLM
| Q4 25 | — | 0.00× | ||
| Q3 25 | — | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $45.6M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $25.7M |
| 自由现金流率自由现金流/营收 | -2.9% | 29.2% |
| 资本支出强度资本支出/营收 | 1.6% | 22.6% |
| 现金转化率经营现金流/净利润 | — | 1.49× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $102.3M |
8季度趋势,按日历期对齐
经营现金流
CTKB
USLM
| Q4 25 | $-771.0K | $45.6M | ||
| Q3 25 | $-3.9M | $45.9M | ||
| Q2 25 | $108.0K | $34.0M | ||
| Q1 25 | $-125.0K | $39.4M | ||
| Q4 24 | $2.0M | $38.6M | ||
| Q3 24 | $13.2M | $39.0M | ||
| Q2 24 | $6.2M | $21.2M | ||
| Q1 24 | $4.0M | $27.2M |
自由现金流
CTKB
USLM
| Q4 25 | $-1.8M | $25.7M | ||
| Q3 25 | $-4.6M | $31.3M | ||
| Q2 25 | $-1.5M | $20.8M | ||
| Q1 25 | $-974.0K | $24.6M | ||
| Q4 24 | $1.1M | $27.6M | ||
| Q3 24 | $12.2M | $33.9M | ||
| Q2 24 | $5.2M | $16.8M | ||
| Q1 24 | $3.4M | $20.3M |
自由现金流率
CTKB
USLM
| Q4 25 | -2.9% | 29.2% | ||
| Q3 25 | -8.7% | 30.7% | ||
| Q2 25 | -3.2% | 22.7% | ||
| Q1 25 | -2.3% | 26.9% | ||
| Q4 24 | 1.9% | 34.4% | ||
| Q3 24 | 23.7% | 37.9% | ||
| Q2 24 | 11.0% | 21.9% | ||
| Q1 24 | 7.6% | 28.4% |
资本支出强度
CTKB
USLM
| Q4 25 | 1.6% | 22.6% | ||
| Q3 25 | 1.3% | 14.4% | ||
| Q2 25 | 3.5% | 14.5% | ||
| Q1 25 | 2.0% | 16.3% | ||
| Q4 24 | 1.6% | 13.8% | ||
| Q3 24 | 2.0% | 5.8% | ||
| Q2 24 | 2.3% | 5.7% | ||
| Q1 24 | 1.3% | 9.5% |
现金转化率
CTKB
USLM
| Q4 25 | — | 1.49× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.10× | ||
| Q1 25 | — | 1.16× | ||
| Q4 24 | 0.21× | 1.43× | ||
| Q3 24 | 14.05× | 1.17× | ||
| Q2 24 | — | 0.81× | ||
| Q1 24 | — | 1.21× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
USLM
暂无分部数据